---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Egonw
description: The 22 members of the fibroblast growth factor (FGF) family of growth
  factors mediate their cellular responses by binding to and activating the different
  isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
  FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
  processes in which cell fate and differentiation to various tissue lineages are
  determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
  sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
  that lead to the variety of cellular responses induced by this large family of growth
  factors. An alternative, FGF-independent, source of FGFR activation originates from
  the interaction with cell adhesion molecules, typically in the context of interactions
  on neural cell membranes and is crucial for neuronal survival and development.<br><br>Upon
  ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is
  activated causing phosphorylation of multiple tyrosine residues on the receptors.
  These then serve as docking sites for the recruitment of SH2 (src homology-2) or
  PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling
  enzymes. Signaling complexes are assembled and recruited to the active receptors
  resulting in a cascade of phosphorylation events.<br><br>This leads to stimulation
  of intracellular signaling pathways that control cell proliferation, cell differentiation,
  cell migration, cell survival and cell shape, depending on the cell type or stage
  of maturation.<br>  View original pathway at:[http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654743
  Reactome].
last-edited: 2018-10-31
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3334
- /instance/WP3334
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3334.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The 22 members of the fibroblast growth factor (FGF) family of growth
    factors mediate their cellular responses by binding to and activating the different
    isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
    FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
    processes in which cell fate and differentiation to various tissue lineages are
    determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
    sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
    that lead to the variety of cellular responses induced by this large family of
    growth factors. An alternative, FGF-independent, source of FGFR activation originates
    from the interaction with cell adhesion molecules, typically in the context of
    interactions on neural cell membranes and is crucial for neuronal survival and
    development.<br><br>Upon ligand binding, receptor dimers are formed and their
    intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine
    residues on the receptors. These then serve as docking sites for the recruitment
    of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors,
    docking proteins or signaling enzymes. Signaling complexes are assembled and recruited
    to the active receptors resulting in a cascade of phosphorylation events.<br><br>This
    leads to stimulation of intracellular signaling pathways that control cell proliferation,
    cell differentiation, cell migration, cell survival and cell shape, depending
    on the cell type or stage of maturation.<br>  View original pathway at:[http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654743
    Reactome].
  keywords:
  - 'FGF18 '
  - 'UBC(381-456) '
  - ''
  - FGFR4:p-FRS2:GRB2:GAB1:PI3K
  - 'BRAF '
  - 'p-5Y-FGFR4 V550E '
  - ATP
  - 'FGFR4 V550E '
  - 'HS '
  - 'p-S112,S121-SPRY2 '
  - FGFR4:p-FRS:PTPN11
  - 'SOS1 '
  - RAF/MAP kinase
  - FRS2
  - 'KLB '
  - GTP
  - PI(4,5)P2
  - Y55/Y227-pSPRY2:CBL
  - 'p-Y55,Y227-SPRY2 '
  - DAG and IP3
  - 'GalNAc-T178-FGF23(25-251) '
  - Activated FGFR4:FRS3
  - 'RPS27A(1-76) '
  - KLB
  - FGFR4-binding FGFs
  - kinase
  - 'FGF16 '
  - 'NRAS '
  - 'PPP2R1A '
  - 'p-S111,S120-SPRY2 '
  - p-T,Y MAPK dimers
  - 'FGF4 '
  - p-4Y-PLCG1
  - 'p-5Y-FGFR4 '
  - 'FGF17-1 '
  - FGFR4:pY-SHC1
  - PLCG1
  - 'UBC(305-380) '
  - 'CBL '
  - 'UBC(457-532) '
  - GRB2-1:SOS1
  - FGFR4
  - FGFR4:PLCG1
  - 'SHC1-3 '
  - Ub-Activated FGFR4
  - 'PPP2CA '
  - 'p-5Y-FGFR4 N535K '
  - CBL
  - signaling
  - Ub:Y55/Y227-pSPRY2:CBL
  - 'SPRY2 '
  - BRAF
  - Ub
  - kinase mutants
  - p-SPRY2:GRB2
  - dimers
  - 'UBA52(1-76) '
  - Activated FGFR4
  - 'p-Y546,Y584-PTPN11 '
  - enhanced kinase
  - PP2A (A:C)
  - FGF19:BetaKlotho
  - PPA2A(A:C):SPRY2
  - ADP
  - PPA2A (A:C):Y55/Y227
  - FGFR4:p-FRS:p-PTPN11
  - 'p-6Y-FRS2 '
  - FGFR4:p-FRS2:GRB2:SOS1
  - PP2A(A:C):SPRY2
  - PP2A(A:C):S112/S121-pSPRY2
  - 'UBC(77-152) '
  - 'p5Y-FGFR4 Y367C mutant '
  - FGFR4:p-FRS2:p-PTPN11
  - 'UBC(153-228) '
  - SHC1-2,SHC1-3
  - p21 RAS:GTP
  - 'GTP '
  - Pi
  - 'FRS3 '
  - 'HRAS '
  - p-T250,T255,T385,S437-MKNK1
  - 'UBB(77-152) '
  - 'FGFR4 N535K '
  - 'p-5Y-FRS3 '
  - 'UBC(609-684) '
  - with enhanced
  - FGFR4 enhanced
  - 'p-T185,Y187-MAPK1 '
  - GRB2-1
  - PP2A(A:C):Y55/Y227-pSPRY2
  - GRB2:GAB1:PIK3R1
  - bound to FGF
  - FGFR4:p-FRS2:p-PTPN11:GRB2:GAB1:PI3K
  - FGFR4:p-FRS3
  - FGFR4 Y367C mutant
  - homodimer
  - 'FGFR4 N535D '
  - FGFR4:p-FRS2
  - 'UBB(153-228) '
  - 'GAB1 '
  - PPA2A
  - 'PPP2CB '
  - SRC-1
  - FGFR4 Y367C
  - 'p-4Y-PLCG1 '
  - FGFR4:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1
  - 'p-5Y-FGFR4 V550L '
  - FGFR4:p-8T-FRS2
  - 'SHC1-2 '
  - 'PIK3R1 '
  - p21 RAS:GDP
  - PIP3 activates AKT
  - PI(3,4,5)P3
  - 'p-S112,S115-SPRY2 '
  - 'FGF1 '
  - 'FGF2(10-155) '
  - 'FGF8-1 '
  - FGFR4:p-4Y-PLCG1
  - 'UBC(1-76) '
  - 'PTPN11 '
  - FGFR4:p-FRS2:GRB2:GAB1:PIK3R1
  - Ub-(Y55/Y227)p-SPRY2
  - mutants
  - FRS3
  - FGFR4 homodimer
  - mutants:PLCG1
  - 'p-Y371-CBL '
  - dimer
  - bound to
  - p-Y371-CBL:GRB2
  - 'UBC(229-304) '
  - 'p-Y194,Y195,Y272-SHC1-3 '
  - 'FGF6 '
  - SPRY2:B-RAF
  - GDP
  - 'Activated FGFR4 enhanced kinase mutants '
  - 'FGF19 '
  - 'UBC(533-608) '
  - Activated
  - FGFR4:p-FRS
  - 'PIK3CA '
  - kinase mutant
  - 'UBB(1-76) '
  - 'p-T202,Y204-MAPK3 '
  - Activated FGFR4:SHC1
  - 'GRB2-1 '
  - 'p-5Y-FGFR4 N535D '
  - FGFR4:p-FRS2:p-PPTN11:p-CBL:GRB2
  - PIK3R1
  - Y367C mutant
  - S111/S120
  - complex:Ub-p-FRS2
  - FGFR4 mutant dimers
  - Activated FGFR4:FRS2
  - 'FRS2 '
  - 'PI(3,4,5)P3 '
  - PIK3CA
  - activity:PD173074
  - 'FGFR4 V550L '
  - mutants:p-4Y-PLCG1
  - 'PLCG1 '
  - 'GDP '
  - p-SPRY2
  - cascade
  - HS
  - p-S111,S120-SPRY2
  - 'p-8T-FRS2 '
  - 'FGFR4 '
  - FGFR4:HS:KLB:FGF19
  - 'KRAS '
  - FGF19
  - 'FGF9 '
  - 'FGF20 '
  - 'FGFR4 Y367C '
  - activated
  - (A:C):S112/S115
  - PD173074
  - GRB2:GAB1
  - PTPN11
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - FGFR4:pY-SHC1:GRB2:SOS1
  - p-SPRY2:B-RAF
  license: CC0
  name: Signaling by FGFR4
seo: CreativeWork
title: Signaling by FGFR4
wpid: WP3334
---